Donor specific antibodies association with survival and adverse events after heart transplantation: A single center retrospective study between 2006 and 2021
Clinical Transplantation2023Vol. 37(4), pp. e14914–e14914
Citations Over TimeTop 11% of 2023 papers
Waqas Akhtar, Mark A. Peterzan, Winston Banya, Brian Olwell, Farveh Vakilian Aghouee, Paul Brookes, John Dunning, Owais Dar
Abstract
This study showed an increased risk of death and MACE in patients developing DSA post heart transplantation. Further research is required into the optimal management of these patients.
Related Papers
- → Prognostic Value of Microvascular Obstruction and Infarct Size, as Measured by CMR in STEMI Patients(2014)361 cited
- → Incidence of Stroke or Systemic Embolism in Paroxysmal Versus Sustained Atrial Fibrillation(2015)118 cited
- → Outcomes of procedural complications in transfemoral transcatheter aortic valve replacement(2021)6 cited
- → Association between office visit intervals and long‐term cardiovascular risk in hypertensive patients(2023)4 cited
- → Prognostic Significance of Heart Rate and its Long-term Trend in Cardiac Transplant Patients(2015)6 cited